Table 1.
Participant characteristics in the full sample and by sequence.
| Total sample (N = 28) | PBO-EP (N = 14) | EP-PBO (N = 14) | ||||
|---|---|---|---|---|---|---|
| n | % | n | % | n | % | |
| Age, years, mean (SD)a | 28.7 (6.8) | 32.1 (6.6) | 25.5 (5.6) | |||
| BMI at recruitment (SD) | 26.3 (6.1) | 28.2 (6.3) | 24.5 (5.3) | |||
| White race | 25 | 89.2 | 12 | 85.7 | 13 | 92.9 |
| Education | ||||||
| <4 yr college degree | 4 | 14.2 | 1 | 7.1 | 3 | 21.4 |
| 4 yr college degree | 15 | 53.6 | 8 | 57.1 | 7 | 50.0 |
| Post-graduate degree | 9 | 32.1 | 5 | 35.7 | 4 | 28.5 |
| Household income | ||||||
| Less than $25,000 | 8 | 28.6 | 1 | 7.1 | 7 | 50.0 |
| $25,000–$49,999 | 8 | 28.6 | 3 | 21.4 | 5 | 35.7 |
| $50,000–$99,999 | 8 | 28.6 | 8 | 57.1 | 0 | 0.0 |
| $100,000 or more | 4 | 14.3 | 2 | 14.2 | 2 | 14.2 |
| Sexual orientation | ||||||
| Heterosexual | 11 | 39.2 | 6 | 42.8 | 5 | 35.7 |
| Bisexual | 8 | 28.6 | 3 | 21.4 | 5 | 35.7 |
| Lesbian/gay | 3 | 10.7 | 0 | 0.0 | 3 | 21.4 |
| Other non-heterosexual | 6 | 21.4 | 5 | 35.7 | 1 | 7.1 |
| Gender (Cisgender) | 26 | 92.8 | 12 | 85.7 | 14 | 100 |
| Cohabitation with partnera | 18 | 64.3 | 12 | 85.7 | 6 | 42.8 |
| Parity | 9 | 32.1 | 5 | 35.7 | 4 | 28.7 |
| Current daily SSRI use | 12 | 42.9 | 7 | 50.0 | 5 | 35.7 |
| Current daily stimulant use | 3 | 10.7 | 2 | 14.2 | 1 | 7.1 |
| Current daily mood stabilizer use | 3 | 10.7 | 1 | 7.1 | 2 | 14.2 |
| Current weekly psychotherapy | 14 | 50.0 | 6 | 42.8 | 8 | 57.1 |
| Lifetime non-suicidal self-injury | 17 | 60.7 | 7 | 50.0 | 10 | 71.4 |
| Lifetime suicide attempt | 16 | 57.1 | 8 | 57.1 | 8 | 57.1 |
| Any depressive disorder | 22 | 78.6 | 12 | 85.7 | 10 | 71.4 |
| Major depressive disorder | 19 | 67.9 | 11 | 78.6 | 8 | 57.1 |
| Persistent depressive disorder | 19 | 67.9 | 10 | 71.4 | 9 | 64.3 |
| Attention deficit/hyp disorder | 4 | 14.3 | 2 | 14.3 | 2 | 14.3 |
| Generalized anxiety disorder | 13 | 46.4 | 7 | 50.0 | 6 | 42.9 |
| Social anxiety disorder | 14 | 50.0 | 7 | 50.0 | 7 | 50.0 |
| Panic disorder | 2 | 7.1 | 1 | 7.1 | 1 | 7.1 |
| Agoraphobia | 3 | 10.7 | 3 | 21.4 | 0 | 0.0 |
| Specific phobia | 7 | 25.0 | 4 | 28.6 | 3 | 21.4 |
| Obsessive–compulsive disorder | 4 | 14.3 | 3 | 21.4 | 1 | 7.1 |
| Anorexia nervosa | 1 | 3.6 | 0 | 0.0 | 1 | 7.1 |
| Bulimia nervosa | 1 | 3.6 | 1 | 7.1 | 0 | 0.0 |
| Post-traumatic stress disorderb | 9 | 32.1 | 2 | 7.1 | 7 | 50.0 |
| Borderline PD | 7 | 25.0 | 5 | 35.7 | 2 | 14.2 |
| Avoidant PD | 6 | 21.4 | 4 | 28.6 | 2 | 14.3 |
| Obsessive–compulsive PD | 2 | 7.1 | 0 | 0.0 | 2 | 14.3 |
| Lifetime physical/sexual abuse | 15 | 53.6 | 8 | 57.1 | 7 | 50.0 |
| Abuse before age 13 | 5 | 17.9 | 2 | 14.3 | 3 | 21.4 |
| C-PASS MRMD (BL cycle) | 0/27 | 0.0 | 0/14 | 0.0 | 0/13 | 0.0 |
| C-PASS PME (BL cycle) | 16/27 | 52.9 | 8/14 | 57.1 | 8/13 | 61.5 |
aPBO-EP > EP-PBO; bEP-PBO > PBO-EP.
BL baseline, PD P-personality disorder, BMI body mass index, MRMD menstrually related mood disorder, as defined by the C-PASS.